The Vox Markets Podcast Podcast By Vox Markets Podcast cover art

The Vox Markets Podcast

The Vox Markets Podcast

By: Vox Markets Podcast
Listen for free

About this listen

Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.Vox Markets Economics Personal Finance
Episodes
  • 2107: Interview with Mike Ralston, CEO & Iain Wearing, COO of Blencowe Resources
    May 30 2025
    Blencowe Resources has been making great strides with its Orom-Cross graphite project in Uganda in recent months, and has recently received a new tranche of funding from the US's Development Finance Corporation. We are joined by Blencowe's chief operating officer Iain Wearing and by chief executive Mike Ralston for an update on progress and an overview of the company's plans and strategy regarding drilling, off-take, production rates and its connections into the US, the EU and the UK.
    Show more Show less
    14 mins
  • 2106: Small-cap Investing with Paul Hill and Paul Scott
    May 28 2025
    Watch on YouTube

    In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 23 stock ideas.

    00:00 Recent buys & sells
    02:25 Begbies Traynor
    05:25 SDI Group
    08:40 SRT Marine
    10:20 Watchlist stocks and Spectra Systems
    13:05 React
    16:30 Bodycote
    19:20 Elementis
    22:35 Avon Technologies & defence stocks
    26:30 M&C Saatchi
    30:35 On the Beach
    33:30 Pets at home
    38:15 Frontier Developments
    41:30 Henry Boot
    44:05 GetBusy
    47:00 Zigup
    50:05 Gamma Communications
    53:05 Alumasc
    55:10 OPG Power
    57:40 Integrated Diagnostics Holding
    58:30 PZ Cussons
    60:40 Curry’s
    63:35 DRX
    64:55 Funding Circle
    66:30 Science Group vs Ricardo
    69:05 Seeing Machines
    Show more Show less
    1 hr and 16 mins
  • 2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
    May 28 2025
    Watch on YouTube

    Following on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
    Show more Show less
    9 mins
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet